This is a comprehensive database of peptides used in research and therapeutics. Each entry includes the peptide sequence, molecular weight, targets, and clinical status.
| Peptide | Sequence | MW (Da) | Target | Status |
|---|
| Semaglutide | See drug label | ~4114 | GLP-1R | FDA approved |
| Insulin (human) | GIVEQCCTSICSLYQLENYCN | 5808 | InsulinR | FDA approved |
| Oxytocin | CYIQNCPLG | 1007 | OxytocinR | FDA approved |
| Leuprolide | pEHWSYGLRPG-NH2 | 1209 | GnRHR | FDA approved |
| Octreotide | SFCNFFWKTCT | 1019 | SSTR | FDA approved |
| Peptide | Sequence | MW (Da) | Application |
|---|
| Melanotan II | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 | 1024 | Tanning research |
| BPC-157 | GEPPPGKPADDAGLV | 1419 | Gut healing research |
| Thymosin alpha 1 | SDAAVDTSSEITTKDLKEK | 2194 | Immunomodulation research |
| Epithalon | AEDGAVTGA | 890 | Aging research |
- Short peptides (2-10 aa): 200-1200 Da
- Medium peptides (11-30 aa): 1200-3500 Da
- Long peptides (31-50 aa): 3500-6000 Da
- Peptide hormones: 1000-5000 Da typically
- N-terminal acetylation: Increases stability
- C-terminal amidation: Mimics natural processing
- Disulfide bridges: Constrain conformation
- PEGylation: Extends half-life
- D-amino acid substitution: Resists proteolysis
